Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Complement fragment 3c Antibody, AbBy Fluor™ 750 Conjugated

Product Specifications

Background

C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates. Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. In chronic inflammation, acts as a chemoattractant for neutrophils (By similarity) . It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C3-beta-c: Acts as a chemoattractant for neutrophils in chronic inflammation. Acylation stimulating protein: adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2 (PubMed:837664, PubMed:29953, PubMed:959512, PubMed:1432298, PubMed:15833747, PubMed:16333141, PubMed:1961575) .

Synonyms

ASP; C3a; C3b; AHUS5; ARMD9; CPAMD1; HEL-S-62p; Complement C3; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1; C3

Gene ID

718

Swiss Prot

P01024

Cellular Locus

Secreted

Host

Rabbit

Cross Reactivity

Human

Immunogen

1051-1200/1663

Target

Complement fragment 3c

Clonality

Polyclonal

Conjugation

AbBy Fluor™ 750

Source

KLH conjugated synthetic peptide derived from human Complement C3c alpha' chain fragment 1

Applications

WB, IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

749nm/775nm

Concentration

1ug/ul

Dilution

WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

718

Isotype

IgG

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

KIF13A CRISPR Activation Plasmid (h)
sc-403751-ACT 20 µg

KIF13A CRISPR Activation Plasmid (h)

Ask
View Details
Aspartate Aminotransferase, NT (Cytoplasmic, Transaminase A, Glutamate Oxaloacetate Transaminase 1, GOT1) (HRP) discontinued
A3879-06A-HRP 200 µL

Aspartate Aminotransferase, NT (Cytoplasmic, Transaminase A, Glutamate Oxaloacetate Transaminase 1, GOT1) (HRP) discontinued

Ask
View Details
PIAS2 (E3 SUMO-protein Ligase PIAS2, Androgen Receptor-interacting Protein 3, ARIP3, DAB2-interacting Protein, DIP, Msx-interacting Zinc Finger Protein, Miz1, PIAS-NY Protein, Protein Inhibitor of Activated STAT x, Protein Inhibitor of Activated STAT2, PIASX, MGC102682) (FITC)
131312-FITC 100 µL

PIAS2 (E3 SUMO-protein Ligase PIAS2, Androgen Receptor-interacting Protein 3, ARIP3, DAB2-interacting Protein, DIP, Msx-interacting Zinc Finger Protein, Miz1, PIAS-NY Protein, Protein Inhibitor of Activated STAT x, Protein Inhibitor of Activated STAT2, PIASX, MGC102682) (FITC)

Ask
View Details
QL6 peptide
HY-P11309 1 Each

QL6 peptide

Ask
View Details
Mixture ME 250 (European Pharm)
MBS394010-01 100 mg

Mixture ME 250 (European Pharm)

Ask
View Details
Mixture ME 250 (European Pharm)
MBS394010-02 5x 100 mg

Mixture ME 250 (European Pharm)

Ask
View Details